The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from government-funded contracts and authorize the Trump administration to bar US investment in Chinese AI and advanced computing.
The Biosecure Act targeting Chinese biotech as well as the FIGHT China Act targeting US investments in technologies with military applications were both included in the latest version of the National Defense Authorization Act agreed to by House and Senate negotiators over the weekend.
The bill omitted a provision strongly opposed by
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.